| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |